Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
Go back to Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics| (NASDAQ: ANAB) | Delayed: 47.78 +2.35 (5.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.43 | 52 Week High | $ | |||
| Open | $45.48 | 52 Week Low | $ | |||
| Day High | $48.48 | P/E | N/A | |||
| Day Low | $45.48 | EPS | $ | |||
| Volume | 354,903 | |||||



